Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease
NCT02242032
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
P-321 Ophthalmic Solution
DRUG:
P-321 Ophthalmic Solution placebo
Sponsor
Parion Sciences